Skip to content
diphenylpyraline

Structure via PubChem · Public domain (PubChem)

EntityQ411150· pop 11· linked from 1,089 articles

diphenylpyraline

Sign in to save

Also known as diphenylpyralamine, 4-(benzhydryloxy)-N-methylpiperidine, 1-methyl-4-hydroxypiperidine benzhydryl ether, 4-(benzhydryloxy)-1-methylpiperidine, 1-methyl-4-piperidyl benzhydryl ether

Diphenylpyraline (DPP; sold as Allergen, Arbid, Belfene, Diafen, Hispril, Histyn, Lergobine, Lyssipol, Mepiben, Neargal) is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. It is marketed in Europe for the treatment of allergies. DPP has also been found to act as a dopamine reuptake inhibitor and produces hyperactivity in rodents. It has been shown to be useful in the treatment of Parkinsonism.

In the Vinony graph

Vinony's link graph records 1,089 inbound references to diphenylpyraline, and connects out to atropine, Anatomical Therapeutic Chemical Classification System and histamine antagonist.

It sits within the topics Diphenylmethanol ethers, Drugs with non-standard legal status and ECHA InfoCard ID from Wikidata.

Vinony links it to 10 Wikipedia language editions.

Chemical data

Formula
C19H23NO
Molecular weight
281.4 g/mol
IUPAC name
4-benzhydryloxy-1-methylpiperidine

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1982
Admin. routes
oral
Indications
allergic disease

via ChEMBL · EBI

Wikidata facts

Mass
281.178
Has use
medication
Show 5 more facts
chemical formula
C₁₉H₂₃NO
canonical SMILES
CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3
World Health Organisation international non-proprietary name
diphenylpyraline
defined daily dose
10.0
Commons category
Diphenylpyraline
Sources (3)

via Wikidata · CC0

~1 min read

Encyclopedic overview

3 sections
Contents
  • Synthesis
  • See also
  • References

Diphenylpyraline (DPP; sold as Allergen, Arbid, Belfene, Diafen, Hispril, Histyn, Lergobine, Lyssipol, Mepiben, Neargal) is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. It is marketed in Europe for the treatment of allergies. DPP has also been found to act as a dopamine reuptake inhibitor and produces hyperactivity in rodents. It has been shown to be useful in the treatment of Parkinsonism.

==Synthesis== 501px|center|class=skin-invert-image

Excerpted from Wikipedia’s “diphenylpyraline” article, available under the CC BY-SA 4.0 licence.

Gallery (2)

Connections

Categories